Developer docs
API playgroundTry for free, no card

Search company profiles

Insempra

Full company profile

uuid0000h8w

Namestring
Insempra
Legal namestring
Insempra GmbH
Websiteurl
insempra.bio
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Insempra GmbH is a Munich-based biotechnology company, founded in 2021 (as Origin.Bio) by Jens Klein and rebranded in July 2022, that develops and produces bio-based ingredients via precision fermentation and cell-free protein synthesis for consumer goods manufacturers in beauty & personal care, food & nutrition, and fibers & performance materials. The company's technology platform combines proprietary microbial strain engineering, a cell-free screening platform established with Northwestern University's Prof. Michael Jewett, and a circular biomanufacturing prototype (BioTreasure) that converts waste streams such as PET, used cooking oil, and plant residues into bio-based products. To date, Insempra has commercialized three fermentation-derived ingredients: natural Alpha-Ionone (a flavor and fragrance ingredient launched April 2023 via Axxence Aromatic), Superior Phenyl Ethyl Alcohol (a >99% purity bio-based fragrance ingredient launched April 2025), and CosVivet ActiLipid O7, an Omega-7 biolipid launched April 2026 under an exclusive global distribution agreement with Brenntag.

The company monetizes through ingredient sales and technology licensing/onboarding of external biotech innovations, using a hybrid B2B model that combines direct sales to consumer goods brands with exclusive third-party distribution partnerships (Brenntag for Omega-7, Axxence for Alpha-Ionone). Insempra has raised approximately $35M in venture funding across a $15M seed (EQT Ventures-led, 2021) and $20M Series A (2024, with new investors including Henkel dx Ventures and Bayern Kapital), and has secured additional non-dilutive grant funding from Germany's SPRIND agency (cumulatively exceeding €6M across three stages of the Circular Biomanufacturing Challenge) and from the Eurostars programme (€2.1M consortium grant for fermentative biomelanin). The company holds a minority strategic stake in Solena Materials, an Imperial College London spin-out developing synthetic protein fibers, which constitutes its entry into the textiles vertical. As of early 2026, Insempra operates from the IZB campus in Planegg/Martinsried with approximately 45 employees across 15 nationalities, has ISO 9001 certification (January 2025), and is led by a team drawn heavily from AMSilk, including CEO Jens Klein, COO Lin Römer, and CTO Andreas Heyl.

Short descriptiontext

Insempra is a Munich-based biotechnology company that develops bio-based ingredients via precision fermentation and cell-free protein synthesis for consumer goods manufacturers in beauty, food, and performance materials, distributing through exclusive partnerships with Brenntag and Axxence Aromatic.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPlanegg, Germany
HQ citystring
Planegg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision fermentation ingredients, bio-based fragrances, fermented specialty lipids, sustainable cosmetic ingredients, circular biomanufacturing
Industry3 codes
PRIMARYIMAEABAJ
Personal Care & Cosmetic Ingredients
SECONDARYEUAAAIAJ
Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYAFAJAKAI
Antioxidants & Phytochemicals (Carotenoids, Tocopherols, Flavonoids, CoQ10, Resveratrol)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
NAICS code4 codes
  • Medicinal and Botanical Manufacturing325411
  • Spice and Extract Manufacturing311942
  • Chemical Manufacturing325
  • Other Basic Organic Chemical Manufacturing32519
SIC code3 codes
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Medicinal Chemicals & Botanical Products2833
  • Industrial Organic Chemicals2860
Product category
Bio-based Ingredients (Precision Fermentation)
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Bio-based Ingredient Sales
TypeOne Time License
Description

Sale of proprietary bio-based ingredients (Superior PEA, Omega-7 biolipid, Alpha-Ionone) to consumer goods manufacturers in beauty, food, and nutrition industries

insempra.bio
2Distribution Revenue
TypeTransaction Fee
Description

Revenue through distribution partners like Brenntag who distribute Insempra's products globally to manufacturers

insempra.bio
3Technology Licensing and Scouting
TypeLicensing Royalties
Description

Technology onboarding, scaling, and licensing services for partners with innovative biotech technologies; vertical or horizontal integration of external innovations

insempra.bio
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales
Pricing details1 tier
1Direct ingredient sales to B2B customers
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Product pricing based on volume and specifications for ingredients like Alpha-Ionone sold to food and beauty manufacturers

insempra.bio
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Insempra develops and produces 100% bio-based ingredients using precision fermentation technology for the beauty & personal care, food & nutrition, and fibers & performance materials industries. The company sells proprietary ingredients such as Superior Phenyl Ethyl Alcohol (fragrance), CosVivet ActiLipid O7 (Omega-7 biolipid for skincare), and natural Alpha-Ionone (flavor & fragrance) to consumer goods manufacturers, distributing globally through partners like Brenntag and Axxence Aromatic.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Eliminated land use equivalent to ~40 football fields by producing raspberry aroma through fermentation instead of farming
+1 more record
Product overview1 text field

Insempra is a biotechnology-powered ingredients platform offering bio-based alternatives across three core verticals: Beauty & Personal Care, Food & Nutrition, and Fibers & Performance Materials. The company utilizes precision fermentation and circular biomanufacturing technologies to produce superior natural ingredients that replace petrochemical-derived and agricultural extract sources. Key products include Superior Phenyl Ethyl Alcohol (fragrance ingredient), CosVivet ActiLipid O7 (Omega-7 biolipid), and Natural Alpha-Ionone (flavour/fragrance), all produced via precision fermentation. The platform leverages second-generation feedstocks from agricultural waste and operates through technology partnerships including distribution via Brenntag and Axxence Aromatic.

Product and service4 records
1Superior Phenyl Ethyl Alcohol (Superior PEA)
CategoryFragrance ingredient (Beauty & Personal Care)
Description

A high-purity (>99%), 100% bio-based fragrance ingredient produced via precision fermentation, featuring a mild rose/honey scent with antimicrobial and antioxidant properties. Designed as a drop-in replacement for beauty and personal care formulators seeking vegan, animal-free, sustainable fragrance ingredients that match or exceed synthetic counterparts.

2CosVivet ActiLipid O7 (Omega-7 Biolipid)
CategorySkincare lipid (Beauty & Personal Care)
Description

Proprietary Omega-7 biolipid developed using precision fermentation for beauty and personal care applications, delivering moisturisation and smooth, supple-looking skin with a silky, lightweight sensory profile. Commercialized through an exclusive global distribution agreement with Brenntag.

3Natural Alpha-Ionone
CategoryFlavor & fragrance ingredient (Food & Beauty)
Description

Biotechnologically produced, 100% natural Alpha-Ionone flavour and fragrance ingredient for food and beauty applications, featuring selective production of the (R)-alpha-Ionone enantiomer for superior violet and raspberry aroma. Distributed globally via supply agreement with Axxence Aromatic GmbH.

4Fermentative Biomelanin
CategoryPersonal care & food colorant/ingredient
Description

First biotechnologically produced vegan melanin developed through a Eurostars consortium collaboration, intended for personal care and food & beverages applications as a sustainable alternative to synthetic or animal-derived melanins.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-07
Description

Exclusive global distribution agreement with Brenntag, the world's largest chemical distributor, to commercialize Insempra's fermentation-derived Omega-7 biolipid (CosVivet ActiLipid O7) for the beauty and personal care industry. The product debuted at in-cosmetics Global in Paris. Brenntag provides access to its network of approximately 600 sites across more than 70 countries. This partnership also signals Brenntag's strategic shift toward building a proprietary bio-based ingredient portfolio.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-20
Description

Eurostars grant consortium awarded €2.1M to develop fermentative biomelanin production. Consortium includes Insempra (Germany), Gecco Biotech (Netherlands), Zymvol Biomodeling (Spain), and University of Groningen. Ranked second out of 216 European consortiums. Three-year project aims to create scalable, vegan biomelanin for personal care and food & beverages applications.

3Fibers365
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-05-25
Description

Collaboration with Fibers365 to develop and scale sustainable second-generation (2G) feedstock for commercial production of fermentation-based ingredients. Fibers365 offers patented modular farm-level Steam Fiber Plants that extract functional cellulosic fibers, lignin and sugars from multi-feedstock non-wood biomass. Successfully tested Fibers365's 2G feedstock derived from agricultural waste streams with Insempra's proprietary fermentation technology platform.

insempra.bio
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-04-04
Description

Supply agreement with Axxence Aromatic GmbH to market Insempra's biotechnologically produced, 100% natural Alpha-Ionone to food and beauty manufacturers globally. Axxence, a leading manufacturer and supplier of natural aroma ingredients, has approximately 110 employees and operates two manufacturing plants in Slovakia, serving customers in over 35 countries including the world's largest F&F companies.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-11-30
Description

Collaboration with BioInnovation Institute to accelerate and support biotech innovation. Insempra mentors BII portfolio companies and advises early-stage startups within synthetic biology. BII opens their network of investors and stakeholders to Insempra. BII is an international commercial foundation supported by the Novo Nordisk Foundation with up to EUR 470 million over 10 years.

6Scientific Advisory Board (Prof. Michael Jewett, Prof. Paul Freemont)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-10-26
Description

Appointment of Professor Michael Jewett (Northwestern University) and Professor Paul Freemont (Imperial College London) to Scientific Advisory Board. Prof. Jewett focuses on synthetic biology for planet and societal health; Prof. Freemont co-founded Imperial College Centre for Synthetic Biology and National UK Innovation and Knowledge Centre for Synthetic Biology.

insempra.bio
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-07-26
Description

Strategic investment in Solena Materials, a spin-out from Imperial College London developing synthetic proteins for high-performance clothing fibers. Insempra CEO Jens Klein serves as Chairman of the Board at Solena. Insempra co-founded Solena and is sole contributing shareholder. Solena is based at Imperial College's Translation & Innovation Hub in White City, London.

Strategic tierCoreTypeOthersAnnounced on2021-10-14
Description

Acquisition of Carbocycle, a Columbia University spinout that developed technology to produce sustainable microbial lipids from upcycled organic waste streams using precision fermentation. Carbocycle's co-founders (Shashwat Vajpeyi, Tim Zeiske, Melanie Valencia) joined Insempra in Munich. Carbocycle was started in 2016 with research funded by the Bill and Melinda Gates Foundation.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest publicly-traded synthetic biology platform company, designing and engineering organisms for industrial applications including food ingredients, fragrances, and specialty chemicals. Directly comparable to Insempra as a precision fermentation platform serving CPG customers, though Ginkgo operates at vastly larger scale with a broader portfolio.

TypeDirect peer
Description

US-based precision fermentation company developing bio-based ingredients for food, flavor, fragrance, nutrition, and personal care via proprietary strain engineering. Closely comparable to Insempra's technology platform and customer verticals, particularly in flavor and fragrance ingredient production.

TypeDirect peer
Description

Pioneer in precision fermentation for sustainable ingredients, notably producing squalane and other specialty chemicals via yeast fermentation for beauty and personal care. Closely comparable technology and end-markets to Insempra, though Amyris has struggled with commercial scale-up and gone through bankruptcy restructuring.

TypeDirect peer
Description

US synthetic biology company specializing in fermentation-derived beauty and personal care ingredients, including bioactive compounds and specialty cosmetic ingredients. Highly comparable to Insempra's Beauty & Personal Care vertical with similar technology approach and customer targets.

TypeDirect peer
Description

Synthetic biology company developing fermentation-derived alternatives to palm oil and other tropical oils for personal care and food applications. Directly comparable to Insempra's Omega-7 biolipid (CosVivet ActiLipid O7) in lipid-based bio-based ingredients for beauty/food.

TypeEmerging player
Description

US company producing specialty chemicals via biocatalysis and fermentation for industrial applications, including personal care ingredients. Comparable to Insempra's specialty ingredients business with similar bio-based chemistry approach.

TypeBroad incumbent
Description

Carbon recycling company using gas fermentation to produce sustainable fuels and chemicals, including specialty ingredients. Comparable as a synthetic biology platform company producing bio-based chemicals at scale, though LanzaTech's primary focus is fuels rather than fragrance/flavor ingredients.

TypeDirect peer
Description

Industrial supplier of vegan silk biopolymers via precision fermentation for cosmetics, textiles, and technical applications. Highly comparable both technologically (precision fermentation for specialty ingredients) and operationally — Insempra's CEO Jens Klein and COO Lin Römer previously led AMSilk, making it a direct pedigree peer.

TypeEmerging player
Description

French biotech company developing enzymatic recycling of PET plastics and producing bio-based monomers via fermentation. Comparable as a European bio-industrial company with precision fermentation capabilities targeting sustainability, though focused on plastics recycling rather than ingredients.

TypeDirect peer
Description

Imperial College spin-out developing synthetic protein fibers for high-performance clothing via precision fermentation. Direct portfolio company of Insempra — Insempra is the sole contributing shareholder and CEO Jens Klein serves as Chairman — making it an operational extension of Insempra's Fibers & Performance Materials vertical.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Insempra

Bio-based Ingredients (Precision Fermentation)insempra.bio

Insempra is a Munich-based biotechnology company that develops bio-based ingredients via precision fermentation and cell-free protein synthesis for consumer goods manufacturers in beauty, food, and performance materials, distributing through exclusive partnerships with Brenntag and Axxence Aromatic.

What Insempra does

Insempra GmbH is a Munich-based biotechnology company, founded in 2021 (as Origin.Bio) by Jens Klein and rebranded in July 2022, that develops and produces bio-based ingredients via precision fermentation and cell-free protein synthesis for consumer goods manufacturers in beauty & personal care, food & nutrition, and fibers & performance materials. The company's technology platform combines proprietary microbial strain engineering, a cell-free screening platform established with Northwestern University's Prof. Michael Jewett, and a circular biomanufacturing prototype (BioTreasure) that converts waste streams such as PET, used cooking oil, and plant residues into bio-based products. To date, Insempra has commercialized three fermentation-derived ingredients: natural Alpha-Ionone (a flavor and fragrance ingredient launched April 2023 via Axxence Aromatic), Superior Phenyl Ethyl Alcohol (a >99% purity bio-based fragrance ingredient launched April 2025), and CosVivet ActiLipid O7, an Omega-7 biolipid launched April 2026 under an exclusive global distribution agreement with Brenntag.

The company monetizes through ingredient sales and technology licensing/onboarding of external biotech innovations, using a hybrid B2B model that combines direct sales to consumer goods brands with exclusive third-party distribution partnerships (Brenntag for Omega-7, Axxence for Alpha-Ionone). Insempra has raised approximately $35M in venture funding across a $15M seed (EQT Ventures-led, 2021) and $20M Series A (2024, with new investors including Henkel dx Ventures and Bayern Kapital), and has secured additional non-dilutive grant funding from Germany's SPRIND agency (cumulatively exceeding €6M across three stages of the Circular Biomanufacturing Challenge) and from the Eurostars programme (€2.1M consortium grant for fermentative biomelanin). The company holds a minority strategic stake in Solena Materials, an Imperial College London spin-out developing synthetic protein fibers, which constitutes its entry into the textiles vertical. As of early 2026, Insempra operates from the IZB campus in Planegg/Martinsried with approximately 45 employees across 15 nationalities, has ISO 9001 certification (January 2025), and is led by a team drawn heavily from AMSilk, including CEO Jens Klein, COO Lin Römer, and CTO Andreas Heyl.

Insempra firmographics

Firmographics
Name
Insempra
Legal name
Insempra GmbH
Website
https://insempra.bio
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Insempra is a Munich-based biotechnology company that develops bio-based ingredients via precision fermentation and cell-free protein synthesis for consumer goods manufacturers in beauty, food, and performance materials, distributing through exclusive partnerships with Brenntag and Axxence Aromatic.
Ownership category
akta.pro rank

Insempra industry classification

Industry
Product category
Bio-based Ingredients (Precision Fermentation)
NAICS
Medicinal and Botanical Manufacturing (325411), Spice and Extract Manufacturing (311942), Chemical Manufacturing (325), Other Basic Organic Chemical Manufacturing (32519)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844), Medicinal Chemicals & Botanical Products (2833), Industrial Organic Chemicals (2860)
akta.pro industry
PRIMARYIMAEABAJ
Personal Care & Cosmetic Ingredients
SECONDARYEUAAAIAJ
Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYAFAJAKAI
Antioxidants & Phytochemicals (Carotenoids, Tocopherols, Flavonoids, CoQ10, Resveratrol)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)

Keywords

  • Precision fermentation ingredients
  • Bio-based fragrances
  • Fermented specialty lipids
  • Sustainable cosmetic ingredients
  • Circular biomanufacturing

Where Insempra is headquartered

Location

Headquarters

HQ city
Planegg
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Insempra business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. Bio-based Ingredient Sales: Sale of proprietary bio-based ingredients (Superior PEA, Omega-7 biolipid, Alpha-Ionone) to consumer goods manufacturers in beauty, food, and nutrition industries
  2. Distribution Revenue: Revenue through distribution partners like Brenntag who distribute Insempra's products globally to manufacturers
  3. Technology Licensing and Scouting: Technology onboarding, scaling, and licensing services for partners with innovative biotech technologies; vertical or horizontal integration of external innovations

Pricing tiers

ModelBillingPrice
Unit PricingMulti-year contractDirect ingredient sales to B2B customers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Insempra product offering

Product offering

Core offering

Insempra develops and produces 100% bio-based ingredients using precision fermentation technology for the beauty & personal care, food & nutrition, and fibers & performance materials industries. The company sells proprietary ingredients such as Superior Phenyl Ethyl Alcohol (fragrance), CosVivet ActiLipid O7 (Omega-7 biolipid for skincare), and natural Alpha-Ionone (flavor & fragrance) to consumer goods manufacturers, distributing globally through partners like Brenntag and Axxence Aromatic.

Product overview

Insempra is a biotechnology-powered ingredients platform offering bio-based alternatives across three core verticals: Beauty & Personal Care, Food & Nutrition, and Fibers & Performance Materials. The company utilizes precision fermentation and circular biomanufacturing technologies to produce superior natural ingredients that replace petrochemical-derived and agricultural extract sources. Key products include Superior Phenyl Ethyl Alcohol (fragrance ingredient), CosVivet ActiLipid O7 (Omega-7 biolipid), and Natural Alpha-Ionone (flavour/fragrance), all produced via precision fermentation. The platform leverages second-generation feedstocks from agricultural waste and operates through technology partnerships including distribution via Brenntag and Axxence Aromatic.

Differentiator

Problem solved

Functional benefit

Products and services

  • Superior Phenyl Ethyl Alcohol (Superior PEA) A high-purity (>99%), 100% bio-based fragrance ingredient produced via precision fermentation, featuring a mild rose/honey scent with antimicrobial and antioxidant properties. Designed as a drop-in replacement for beauty and personal care formulators seeking vegan, animal-free, sustainable fragrance ingredients that match or exceed synthetic counterparts.
  • CosVivet ActiLipid O7 (Omega-7 Biolipid) Proprietary Omega-7 biolipid developed using precision fermentation for beauty and personal care applications, delivering moisturisation and smooth, supple-looking skin with a silky, lightweight sensory profile. Commercialized through an exclusive global distribution agreement with Brenntag.
  • Natural Alpha-Ionone Biotechnologically produced, 100% natural Alpha-Ionone flavour and fragrance ingredient for food and beauty applications, featuring selective production of the (R)-alpha-Ionone enantiomer for superior violet and raspberry aroma. Distributed globally via supply agreement with Axxence Aromatic GmbH.
  • Fermentative Biomelanin First biotechnologically produced vegan melanin developed through a Eurostars consortium collaboration, intended for personal care and food & beverages applications as a sustainable alternative to synthetic or animal-derived melanins.

Quantifiable outcome

  • Eliminated land use equivalent to ~40 football fields by producing raspberry aroma through fermentation instead of farming
  • +1 more outcomes

Companies that use Insempra

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles4 records

Insempra technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Insempra partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • BrenntagcoreChannel Partner/ Reseller/ Distributor · 7 April 2026Exclusive global distribution agreement with Brenntag, the world's largest chemical distributor, to commercialize Insempra's fermentation-derived Omega-7 biolipid (CosVivet ActiLipid O7) for the beauty and personal care industry. The product debuted at in-cosmetics Global in Paris. Brenntag provides access to its network of approximately 600 sites across more than 70 countries. This partnership also signals Brenntag's strategic shift toward building a proprietary bio-based ingredient portfolio.
  • Eurostars Consortium (Gecco Biotech, Zymvol Biomodeling, University of Groningen)coreStrategic or Co-development Partner · 20 February 2024Eurostars grant consortium awarded €2.1M to develop fermentative biomelanin production. Consortium includes Insempra (Germany), Gecco Biotech (Netherlands), Zymvol Biomodeling (Spain), and University of Groningen. Ranked second out of 216 European consortiums. Three-year project aims to create scalable, vegan biomelanin for personal care and food & beverages applications.
  • Fibers365coreStrategic or Co-development Partner · 25 May 2023Collaboration with Fibers365 to develop and scale sustainable second-generation (2G) feedstock for commercial production of fermentation-based ingredients. Fibers365 offers patented modular farm-level Steam Fiber Plants that extract functional cellulosic fibers, lignin and sugars from multi-feedstock non-wood biomass. Successfully tested Fibers365's 2G feedstock derived from agricultural waste streams with Insempra's proprietary fermentation technology platform.
  • Axxence Aromatic GmbHcoreChannel Partner/ Reseller/ Distributor · 4 April 2023Supply agreement with Axxence Aromatic GmbH to market Insempra's biotechnologically produced, 100% natural Alpha-Ionone to food and beauty manufacturers globally. Axxence, a leading manufacturer and supplier of natural aroma ingredients, has approximately 110 employees and operates two manufacturing plants in Slovakia, serving customers in over 35 countries including the world's largest F&F companies.
  • BioInnovation Institute (BII)minorStrategic or Co-development Partner · 30 November 2022Collaboration with BioInnovation Institute to accelerate and support biotech innovation. Insempra mentors BII portfolio companies and advises early-stage startups within synthetic biology. BII opens their network of investors and stakeholders to Insempra. BII is an international commercial foundation supported by the Novo Nordisk Foundation with up to EUR 470 million over 10 years.
  • Scientific Advisory Board (Prof. Michael Jewett, Prof. Paul Freemont)minorStrategic or Co-development Partner · 26 October 2022Appointment of Professor Michael Jewett (Northwestern University) and Professor Paul Freemont (Imperial College London) to Scientific Advisory Board. Prof. Jewett focuses on synthetic biology for planet and societal health; Prof. Freemont co-founded Imperial College Centre for Synthetic Biology and National UK Innovation and Knowledge Centre for Synthetic Biology.
  • Solena MaterialscoreStrategic or Co-development Partner · 26 July 2022Strategic investment in Solena Materials, a spin-out from Imperial College London developing synthetic proteins for high-performance clothing fibers. Insempra CEO Jens Klein serves as Chairman of the Board at Solena. Insempra co-founded Solena and is sole contributing shareholder. Solena is based at Imperial College's Translation & Innovation Hub in White City, London.
  • CarbocyclecoreOthers · 14 October 2021Acquisition of Carbocycle, a Columbia University spinout that developed technology to produce sustainable microbial lipids from upcycled organic waste streams using precision fermentation. Carbocycle's co-founders (Shashwat Vajpeyi, Tim Zeiske, Melanie Valencia) joined Insempra in Munich. Carbocycle was started in 2016 with research funded by the Bill and Melinda Gates Foundation.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Insempra competitors and assessment

Company assessment

Broad incumbents

  • Ginkgo Bioworks: Largest publicly-traded synthetic biology platform company, designing and engineering organisms for industrial applications including food ingredients, fragrances, and specialty chemicals. Directly comparable to Insempra as a precision fermentation platform serving CPG customers, though Ginkgo operates at vastly larger scale with a broader portfolio.
  • LanzaTech: Carbon recycling company using gas fermentation to produce sustainable fuels and chemicals, including specialty ingredients. Comparable as a synthetic biology platform company producing bio-based chemicals at scale, though LanzaTech's primary focus is fuels rather than fragrance/flavor ingredients.

Direct peers

  • Conagen: US-based precision fermentation company developing bio-based ingredients for food, flavor, fragrance, nutrition, and personal care via proprietary strain engineering. Closely comparable to Insempra's technology platform and customer verticals, particularly in flavor and fragrance ingredient production.
  • Amyris: Pioneer in precision fermentation for sustainable ingredients, notably producing squalane and other specialty chemicals via yeast fermentation for beauty and personal care. Closely comparable technology and end-markets to Insempra, though Amyris has struggled with commercial scale-up and gone through bankruptcy restructuring.
  • Debut Biotechnology: US synthetic biology company specializing in fermentation-derived beauty and personal care ingredients, including bioactive compounds and specialty cosmetic ingredients. Highly comparable to Insempra's Beauty & Personal Care vertical with similar technology approach and customer targets.
  • C16 Biosciences: Synthetic biology company developing fermentation-derived alternatives to palm oil and other tropical oils for personal care and food applications. Directly comparable to Insempra's Omega-7 biolipid (CosVivet ActiLipid O7) in lipid-based bio-based ingredients for beauty/food.
  • AMSilk: Industrial supplier of vegan silk biopolymers via precision fermentation for cosmetics, textiles, and technical applications. Highly comparable both technologically (precision fermentation for specialty ingredients) and operationally — Insempra's CEO Jens Klein and COO Lin Römer previously led AMSilk, making it a direct pedigree peer.
  • Solena Materials: Imperial College spin-out developing synthetic protein fibers for high-performance clothing via precision fermentation. Direct portfolio company of Insempra — Insempra is the sole contributing shareholder and CEO Jens Klein serves as Chairman — making it an operational extension of Insempra's Fibers & Performance Materials vertical.

Emerging players

  • Solugen: US company producing specialty chemicals via biocatalysis and fermentation for industrial applications, including personal care ingredients. Comparable to Insempra's specialty ingredients business with similar bio-based chemistry approach.
  • Carbios: French biotech company developing enzymatic recycling of PET plastics and producing bio-based monomers via fermentation. Comparable as a European bio-industrial company with precision fermentation capabilities targeting sustainability, though focused on plastics recycling rather than ingredients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Insempra social profiles

Digital presence

Insempra compliance and trust

Trust signal

Compliance2 records

Insempra financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Insempra leadership team

Management profile

Number of profiles

Profiles13 records

Insempra subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Insempra funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Insempra M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Insempra

What does Insempra do?

Insempra develops and produces 100% bio-based ingredients using precision fermentation technology for the beauty & personal care, food & nutrition, and fibers & performance materials industries. The company sells proprietary ingredients such as Superior Phenyl Ethyl Alcohol (fragrance), CosVivet ActiLipid O7 (Omega-7 biolipid for skincare), and natural Alpha-Ionone (flavor & fragrance) to consumer goods manufacturers, distributing globally through partners like Brenntag and Axxence Aromatic.

Is Insempra a public or private company?

Insempra is a private company. It is classified as venture growth investor backed and is currently operating.

When was Insempra founded?

Insempra was founded in 2021. It employs 11 to 50 people.

Where is Insempra based?

Insempra is headquartered in Planegg, Germany, in the Europe region.

How does Insempra make money?

Three revenue lines are on record. Bio-based Ingredient Sales are the primary driver. The others are distribution Revenue and technology Licensing and Scouting.

Who are Insempra's main competitors?

Broad incumbents on record are Ginkgo Bioworks and LanzaTech. Direct peers are Conagen, Amyris, Debut Biotechnology, C16 Biosciences, AMSilk and Solena Materials. Emerging players are Solugen and Carbios.

Does Insempra have an API?

No public API is recorded for Insempra.

What industry is Insempra in?

Insempra's product category is Bio-based Ingredients (Precision Fermentation). Its primary akta.pro industry code is IMAEABAJ, Personal Care & Cosmetic Ingredients, with a secondary code of EUAAAIAJ, Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors). Its NAICS code is 325411 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SynBioBetaThe World's Largest Chemical Distributor Just Placed Its Bet on Insempra and Precision FermentationInsempra, a precision fermentation biotech company, has signed an exclusive global distribution agreement with Brenntag, the world's largest chemical distributor, to commercialize its fermentation-derived Omega-7 biolipid for the beauty and personal care industry. The product, CosVivet ActiLipid O7, will debut at in-cosmetics Global in Paris on April 15, with Brenntag providing access to its network of approximately 600 sites across more than 70 countries. The partnership also signals Brenntag's strategic shift toward building a proprietary bio-based ingredient portfolio, suggesting industrial biotech companies may increasingly leverage established distributor networks to scale commercialization.WorldbiomarketinsightsBioTreasure lands €2.5M to scale bio-chemical platformMunich-based BioTreasure has secured €2.5 million in funding from Germany's Federal Agency for Disruptive Innovation (SPRIND) to advance its integrated bio-chemical manufacturing platform to Stage III of SPRIND's Circular Biomanufacturing Challenge, progressing toward industrial deployment. The platform combines biological fermentation with proprietary chemical conversion to produce bio-based chemicals for advanced materials, personal and home care, and agrochemical markets, targeting a combined market opportunity of €400 billion. BioTreasure was established through collaboration between SPRIND and Insempra, building on Insempra's industrial biotechnology experience.GreenqueenUK Startup Raises $6.7M to Scale AI-Designed Microbial Protein Fibres for Next-Gen TextilesLondon-based Solena Materials has secured $6.7M in seed funding led by Sir David Harding, SynBioVen, and Insempra to scale production of AI-designed microbial protein fibres. This investment brings the startup's total funding to $10.8M, enabling it to expand capacity and collaborate with partner brands to launch plastic-free, biodegradable textiles within the next three years.deutsche-startups.de+++ iwoca +++ Lilium +++ Insempra +++ Testmate +++ Ikerian +++ Charly +++In recent developments in the German-speaking startup scene, several companies received notable investments and acquisitions. iwoca secured €314 million in loans from multiple financial institutions, while Lilium attracted up to $150 million from Yorkville Advisors, among various other transactions involving startups like Insempra, Testmate, Ikerian, and stylink. Additionally, stylink acquired the company getnano, and e-fellows.net took over the startup Charly.FinSMEsInsempra Closes $20M FinancingInsempra, a Munich-based biotechnology company, raised $20M from EQT Ventures, BlueYard Capital, and others. The funds will support its technology platform for sustainable ingredients and scale up development and manufacturing. The company is growing lipids for cosmetic and food applications and developing bio-based alternatives to polymers and textiles.Silicon Valley JournalsInsempra raised $20M Series A to advance bio-based alternativesGerman biotech company Insempra has raised $20 million in Series A financing to advance its bio-based manufacturing alternatives. The investment round included participation from existing investors such as EQT Ventures and BlueYard Capital, alongside new backers including Henkel dx Ventures and Bayern Kapital. This funding will support Insempra's mission to replace harmful industrial chemicals with superior natural ingredients across sectors like cosmetics and textiles.Tech.euInsempra secures $20M Series A to advance bio-based alternatives in manufacturingGerman biotech Insempra completed a $20 million Series A financing round to scale its bio-based manufacturing technology. The funds will support technology scaleup, scouting, development, and manufacturing capabilities. The company aims to produce natural ingredients for cosmetics, food, and materials like polymers and textiles.YahooAfter a $20M Series A funding, Germany's Insempra plans eco-friendly lipid productionGerman startup Insempra raised a $20 million Series A led by EQT Ventures to scale yeast fermentation for producing lipids from oil yeast. The company also develops bio-based alternatives for polymers and textiles, with investors including Henkel. It plans to produce ingredients for cosmetics, food, and fashion fibers.InsempraInsempra completes $20 million financing to advance the development of next-generation bio-based ingredients. – Insempra®Insempra completed a $20 million Series A financing round to accelerate the development of bio-based ingredients for the beauty and food industries. The investment was led by existing backers EQT Ventures, BlueYard Capital, Possible Ventures, Taavet Sten, and Acequia Capital, with new participation from Henkel dx Ventures, Bayern Kapital, and Alante Capital. This funding will support Insempra's technology scouting, development, and manufacturing scale-up capabilities.